Source link : https://newshealth.biz/health-news/regimen-improves-pfs-in-highly-mutated-metastatic-colorectal-cancer/
(MedPage Today) — SAN FRANCISCO — Adding modified FOLFOX6 (oxaliplatin, leucovorin, and fluorouracil) and bevacizumab (Avastin) to atezolizumab (Tecentriq) significantly improved progression-free survival (PFS) in patients with previously untreated… Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119392 Author : Publish date : 2026-01-12 21:39:00 Copyright for syndicated content belongs to the linked Source.
The post Regimen Improves PFS in Highly Mutated Metastatic Colorectal Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-01-12 21:39:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8